Issue 16, 2009

Hybrid gadolinium oxide nanoparticles combining imaging and therapy

Abstract

The cytotoxicity of luminescent paramagnetic gadolinium oxide nanoparticles activated by harmless thermal neutron irradiation was evaluated on a luciferase coding gene transfected lymphome cells (EL4-Luc). Cellular uptake of nanoparticles was determined by fluorescence and magnetic resonance imaging and by ICP-MS analyses while the metabolic activity of irradiated EL4-Luc cells was monitored by bioluminescence. The alteration of the irradiated cells depends both on neutron irradiation dose and on gadolinium content within cells. In addition to their dual modality imaging ability, the application of these multifunctional particles for neutron capture therapy can be envisaged.

Graphical abstract: Hybrid gadolinium oxide nanoparticles combining imaging and therapy

Article information

Article type
Paper
Submitted
10 Sep 2008
Accepted
14 Jan 2009
First published
02 Mar 2009

J. Mater. Chem., 2009,19, 2328-2335

Hybrid gadolinium oxide nanoparticles combining imaging and therapy

J. Bridot, D. Dayde, C. Rivière, C. Mandon, C. Billotey, S. Lerondel, R. Sabattier, G. Cartron, A. Le Pape, G. Blondiaux, M. Janier, P. Perriat, S. Roux and O. Tillement, J. Mater. Chem., 2009, 19, 2328 DOI: 10.1039/B815836C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements